Concepedia

Mark Paris

MP

20

Publications

1.3K

Citations

17

H-Index

1994

Active since

Affiliations

Vaccinex (United States)(Current)

Cleveland Clinic

Universidad Peruana Cayetano Heredia

Icahn School of Medicine at Mount Sinai

Cleveland Clinic Lerner College of Medicine

Mark Paris is an author at Vaccinex (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1994–2016

20

Publications

20

Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene

Yasuhiko Nishio, Yufeng Dong, Mark Paris et al. · Gene · 2006 · 342 citations

, , +4

CXCL13 antibody for the treatment of autoimmune disorders

Ekaterina Klimatcheva, Tracy Pandina, Christine Reilly et al. · BMC Immunology · 2015 · 122 citations · Full text

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

Ernest Smith, Alan S. Jonason, Christine Reilly et al. · Neurobiology of Disease · 2014 · 112 citations · Full text

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

Elizabeth E. Evans, Alan S. Jonason, Sebold Torno et al. · Cancer Immunology Research · 2015 · 105 citations · Full text

Ocular Manifestations Associated with Brucellosis: A 26‐Year Experience in Peru

I. Rolando, Liset Olarte, Gustavo Vilchez et al. · Clinical Infectious Diseases · 2008 · 78 citations · Full text

Rows per page

1–5 of 20